Story thread · 4 reports / 4 sources
STAT+: Vera kidney drug Trutakna shows strong final results in Phase 3 trial
statnews.com · 3h · first report
How the coverage leans
Across 4 sources · syndicated copies counted once
The drug stabilized kidney function and reduced the risk of death and other complications in IgAN patients
The coverage
- Vera Makes A Bullish Move — Times Three. Will It Hold Up To Competition?
investors.com · 27m
- Vera set for full FDA approval of Trutakna after late-stage trial win
seekingalpha.com · 2h
- Vera eyes full approval for Trutakna in IgAN following positive readout
endpts.com · 3h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.